MEDOF(MEDOF)
MEDOF
No analyst ratings available
No analyst price targets available for MEDOF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $2.11B | $2.20B | $2.35B |
| Low | $2.06B | $2.14B | $2.29B |
| High | $2.15B | $2.24B | $2.40B |
| EBITDA Avg | $120M | $125M | $134M |
| Low | $117M | $122M | $131M |
| High | $123M | $128M | $137M |
| EBIT Avg | $71M | $74M | $79M |
| Low | $69M | $72M | $77M |
| High | $72M | $75M | $80M |
| Net Income Avg | $35M | $42M | — |
| Low | $33M | $41M | — |
| High | $35M | $43M | — |
| EPS Avg | $1.38 | $1.69 | — |
| Low | $1.34 | $1.64 | — |
| High | $1.42 | $1.73 | — |
| Analysts (Rev / EPS) | 4 / 1 | 4 / 1 | 2 / — |